Abstract

Sapindus mukorossi is a deciduous plant and has recently been recognized to have anticancer property. In the present study, we discovered that S. mukorossi leaf and stem aqueous extract (SaM) contained two polysaccharides mainly made of myo-inositol, galactose, glucose, and fructose and the aim of this study was to investigate the antitumor property the aqueous extract SaM. In vitro treatment of SaM diminished proliferative potential of lung adenocarcinomic cells and induced intracellular oxidative stress, as well as necrotic cell death. Moreover, exposure to SaM attenuated cell migration, demonstrating the effectiveness at reducing invasive property of malignant lung cells. Gene and protein expression studies indicated that SaM treatment altered the expression of proliferation/survival modulator NF-κB, tumor growth modulator ERK2, metastasis-associated molecules MMP9/12, and tumor suppressor p53 in A549 cells. Using model animals bearing Lewis lung cancer cell LL/2, we demonstrated that SaM was antitumoral and did not induce any undesired organ damage, immunotoxicity, and off-target inflammation. This work, to our knowledge, is the first study documents the antitumor bioactivity of aqueous extract riched in polysaccharides from S. mukorossi and provides insights into the potential pharmacological application of SaM as antitumor agent against lung cancer.

Highlights

  • Sapindus mukorossi (Sapindaceae), known as the soapnuts, is a deciduous plant widely distributed in the tropical and sub-tropical regions of Asia

  • Lung cancer is generally classified into two main types: the non-small cell lung cancer (NSCLC; 80% of diagnosed cases) and the small cell lung cancer (SCLC; 20% of diagnosed cases)

  • We discovered the aqueous extract of S. mukorossi stem and leaf, named as SaM, is rich in polysaccharides

Read more

Summary

Introduction

Sapindus mukorossi (Sapindaceae), known as the soapnuts, is a deciduous plant widely distributed in the tropical and sub-tropical regions of Asia. Hepatoprotective, anti- inflammatory, and antitumor properties of S. mukorossi have been reported. In addition to these pharmacological properties, S. mukorossi has been demonstrated to be antitumoral against several types of tumor such as liver carcinomic Hepa59T/VGH cells, large lung carcinomic NCI cells, cervical epithelioid carcinomic HeLa cells, medulloblastoma Med/Daoy, colon adenocarcinomic WiDr cells, and oral epidermoid carcinomic KB cells[8,9]. Despite all our advances in managing cancers, providing a curative therapy regimen for the patients with non-small lung cancer remains to be a challenge to many oncologists. Patients with NSCLC usually have to undergo intensive surgery treatment depending on the disease stage at diagnosis and the patient’s performance status. Therapeutic agents derived from several herbal plants, such as Platycodon grandiflorum (Campanulaceae), Morus alba (Moraceae), Rhus verniciflua (Anacardiaceae), Perilla frutescens (Labiatae), Stemona japonica (Stemonaceae), Tussilago farfara (Compositae) and Draba nemorosa (Brassicaceae), have been used conventionally as folk remedies for treating lung diseases, including cancer[10]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call